Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, Solventum Corporation (SOLV) has a Wall Street consensus price target of $95.80, based on estimates from 11 covering analysts. With the stock currently trading at $74.20, this represents a potential upside of +29.1%. The company has a market capitalization of $12.87B.
Analyst price targets range from a low of $77.00 to a high of $105.00, representing a 29% spread in expectations. The median target of $100.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 7 analysts rating the stock as a Buy or Strong Buy,3 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, SOLV trades at a trailing P/E of 8.4x and forward P/E of 11.5x. Analysts expect EPS to grow -27.6% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $63.78, with bear and bull scenarios of $33.10 and $80.90 respectively. Model confidence stands at 51/100, reflecting moderate uncertainty in projections.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how SOLV stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus Wall Street price target for SOLV is $95.8, representing 29.1% upside from the current price of $74.2. With 11 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
SOLV has a consensus rating of "Buy" based on 11 Wall Street analysts. The rating breakdown is predominantly bullish, with 7 Buy/Strong Buy ratings. The consensus 12-month price target of $95.8 implies 29.1% upside from current levels.
With a forward P/E of 11.5416x, SOLV trades at a relatively low valuation. The consensus target of $95.8 implies 29.1% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $105 for SOLV, while the most conservative target is $77. The consensus of $95.8 represents the median expectation. Our quantitative valuation model projects a bull case target of $81 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
SOLV is moderately covered, with 11 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 7 have Buy ratings, 3 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month SOLV stock forecast based on 11 Wall Street analysts shows a consensus price target of $95.8, with estimates ranging from $77 (bear case) to $105 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $64, with bear/bull scenarios of $33/$81.
Our quantitative valuation model calculates SOLV's fair value at $64 (base case), with a bear case of $33 and bull case of $81. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 51/100.
SOLV trades at a forward P/E ratio of 11.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 8.4x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on SOLV, with a "Buy" consensus rating and $95.8 price target (29.1% upside). 7 of 11 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
SOLV analyst price targets range from $77 to $105, a 29% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $95.8 consensus represents the middle ground. Our model's $33-$81 range provides an independent fundamental perspective.